Peapod Bio Announces In-House 200,000-Compound Library Through Partnership with Enamine

Peapod Bio is excited to announce a new partnership with Enamine, Ltd, a global leader in small-molecule libraries, significantly expanding the discovery power available to our clients. Through this collaboration, Peapod Bio now offers an in-house collection of 200,000 diverse, pharmacophore-like compounds, available as singletons or pooled formats to be screened using a wide array of biochemical and affinity selection mass spectrometry (ASMS) assays.

This newly integrated library brings unprecedented chemical breadth to our assay development and high-throughput screening workflows, enabling faster identification of high-value hits and smoother progression into downstream optimization

This collaboration brings together complementary strengths, exceptional chemistry, and cutting-edge screening solutions. Together, we’re advancing comprehensive drug discovery solutions.

With this expanded capability, Peapod Bio continues to strengthen its position as a next-generation CRO that blends innovative assay design with powerful screening technologies, assisting partners accelerate discovery from concept to candidate.

For inquiries about accessing the library or integrating it into your next screening campaign, please contact our team and read the full press release here.